Proquad market report points to faster growth in Asia-Pacific
The Business Research Company says the global Proquad vaccine market is set for growth through 2030, driven by routine childhood vaccination programs, rising measles and chickenpox cases, and higher healthcare spending. North America led the market in 2025, while Asia-Pacific is expected to post the fastest growth.
Why it matters: - Proquad combines protection against measles, mumps, rubella and varicella in one shot, which can simplify pediatric immunization schedules and improve vaccine coverage. - The market outlook matters because measles and chickenpox outbreaks continue to underscore demand for broader vaccination access and stronger immunization programs. - The report says rising healthcare spending, vaccine logistics improvements and public-private partnerships could support wider adoption through 2030.
What happened: - The Business Research Company released a new Proquad market report on Nov. 10, 2026, covering market trends, segment details and business strategies. - The report says the Proquad vaccine market is poised for considerable developments between 2026 and 2030. - The report identifies North America as the largest market in 2025. - The report expects Asia-Pacific to be the fastest-growing region during 2026 to 2030.
The details: - Proquad is a combination vaccine used to protect against measles, mumps, rubella and varicella, also known as chickenpox. - The vaccine is typically given as a single dose to children between 12 months and 12 years old. - The report links historical market growth to routine childhood vaccination programs, higher public awareness, improved pediatric healthcare infrastructure, wider availability of combination vaccines and government-backed immunization funding. - The report says future growth will be supported by efforts to increase vaccination coverage targets, investments in next-generation vaccine development and stronger monitoring of immunization compliance. - Additional expected trends include greater adoption of combination vaccines, expanded national immunization programs, optimization of cold chain systems and enhanced vaccine safety monitoring. - The report says increasing measles and chickenpox incidence is a major market driver. - The report cites World Health Organization data showing 56,634 measles cases and four deaths across 45 of 53 countries in the WHO European Region in the first quarter of 2024. - The report says growing healthcare spending supports immunization budgets, vaccine access, public awareness and insurance coverage. - The report cites UK healthcare expenditure of about $362 billion, or £292 billion, in 2023, up 5.6% nominally. - The report also cites a 2.8% real-term increase in UK spending on long-term health and social care in 2022. - The regional analysis covers Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The report says its 2026 editions include market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel-based dashboards, market hotspots infographics, and updated graphics and tables. - The company offers a free sample of the report at the sample request page. - The full report is available at the Proquad market report page.
Between the lines: - The report is signaling that combination vaccines may gain more traction as health systems look for simpler delivery and broader coverage. - The regional growth split suggests mature markets are already established, while emerging demand is likely to come from countries expanding routine immunization programs. - The emphasis on safety monitoring and cold chain systems points to execution, not just demand, as a key factor in market growth.
What's next: - The report expects the market’s next phase to be shaped by vaccination coverage expansion, logistics improvements and continued investment in vaccine development. - The company says its expanded strategic intelligence tools are intended to help readers track market opportunities and regional hotspots.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
Asia News Digest
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.